# BRAFTOVI
> **NDA210496** · New Drug Application · Sponsor: ARRAY BIOPHARMA INC · Approved 2018-06-27
## Drug
- **FDA Application Number:** NDA210496
- **Application type:** New Drug Application
- **Brand name:** BRAFTOVI
- **Generic name:** ENCORAFENIB
- **Active ingredients:** ENCORAFENIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ARRAY BIOPHARMA INC
- **Manufacturer:** Array BioPharma Inc.
- **First approval:** 2018-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210496)
---
*AI Analytics · CC0 1.0*